BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Takino JI, Nagamine K, Hori T, Sakasai-Sakai A, Takeuchi M. Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma. World J Hepatol 2015; 7(23): 2459-2469 [PMID: 26483867 DOI: 10.4254/wjh.v7.i23.2459]
URL: https://www.wjgnet.com/1948-5182/full/v7/i23/2459.htm
Number Citing Articles
1
Magdalena Świderska, Mateusz Maciejczyk, Anna Zalewska, Joanna Pogorzelska, Robert Flisiak, Adrian Chabowski. Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patientsFree Radical Research 2019; 53(8): 841 doi: 10.1080/10715762.2019.1635691
2
Masa-Ki Inoue, Yusuke Nakatsu, Takeshi Yamamotoya, Shun Hasei, Mayu Kanamoto, Miki Naitou, Yasuka Matsunaga, Hideyuki Sakoda, Midori Fujishiro, Hiraku Ono, Akifumi Kushiyama, Tomoichiro Asano. Pin1 Plays Essential Roles in NASH Development by Modulating Multiple Target ProteinsCells 2019; 8(12): 1545 doi: 10.3390/cells8121545
3
Mohd W. A. Khan, Ahmed A. Otaibi, Arwa F. M. Alhumaid, Abdulmohsen K. D. Alsukaibi, Asma K. Alshamari, Eida M. Alshammari, Salma A. Al-Zahrani, Ahmed Y. M. Almudyani, Subuhi Sherwani. Garlic Extract: Inhibition of Biochemical and Biophysical Changes in Glycated HSAApplied Sciences 2021; 11(22): 11028 doi: 10.3390/app112211028
4
Nataliia Petriv, Lavinia Neubert, Myroslava Vatashchuk, Kai Timrott, Huizhen Suo, Inga Hochnadel, René Huber, Christina Petzold, Anastasiia Hrushchenko, Andriy S. Yatsenko, Halyna R. Shcherbata, Heiner Wedemeyer, Ralf Lichtinghagen, Halina Falfushynska, Volodymyr Lushchak, Michael P. Manns, Heike Bantel, Halyna Semchyshyn, Tetyana Yevsa. Increase of α-dicarbonyls in liver and receptor for advanced glycation end products on immune cells are linked to nonalcoholic fatty liver disease and liver cancerOncoImmunology 2021; 10(1) doi: 10.1080/2162402X.2021.1874159
5
Masayoshi Takeuchi, Akiko Sakasai-Sakai, Takanobu Takata, Jun-ichi Takino, Yoshiki Koriyama, Chigusa Kikuchi, Ayako Furukawa, Kentaro Nagamine, Takamitsu Hori, Tamihide Matsunaga. Intracellular Toxic AGEs (TAGE) Triggers Numerous Types of Cell DamageBiomolecules 2021; 11(3): 387 doi: 10.3390/biom11030387
6
Brett J. West, Shixin Deng, Akemi Uwaya, Fumiyuki Isami, Yumi Abe, Sho-ichi Yamagishi, C. Jarakae Jensen. Iridoids are natural glycation inhibitorsGlycoconjugate Journal 2016; 33(4): 671 doi: 10.1007/s10719-016-9695-x
7
Kathleen Priken, Gladys Tapia, Cynthia Cadagan, Nicolás Quezada, Javiera Torres, Amanda D'Espessailles, Paulina Pettinelli. Higher hepatic advanced glycation end products and liver damage markers are associated with non-alcoholic steatohepatitisNutrition Research 2022;  doi: 10.1016/j.nutres.2022.04.005
8
Takanobu Takata, Akiko Sakasai-Sakai, Tadashi Ueda, Masayoshi Takeuchi. Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular diseaseScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-39202-5
9
Stefano Menini, Carla Iacobini, Martina Vitale, Carlo Pesce, Giuseppe Pugliese. Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl StressCancers 2021; 13(2): 313 doi: 10.3390/cancers13020313
10
Xiao-Bin Fang, Ying-Qi Xu, Hon-Fai Chan, Chun-Ming Wang, Qing Zheng, Fei Xiao, Mei-Wan Chen. A Redox-Sensitive and RAGE-Targeting Nanocarrier for Hepatocellular Carcinoma TherapyMolecular Pharmaceutics 2016; 13(11): 3613 doi: 10.1021/acs.molpharmaceut.6b00116
11
Sabine Matou-Nasri, Hana Sharaf, Qiuyu Wang, Nasser Almobadel, Zaki Rabhan, Hamad Al-Eidi, Wesam Bin Yahya, Thadeo Trivilegio, Rizwan Ali, Nasser Al-Shanti, Nessar Ahmed. Biological impact of advanced glycation endproducts on estrogen receptor-positive MCF-7 breast cancer cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2017; 1863(11): 2808 doi: 10.1016/j.bbadis.2017.07.011
12
Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and MortalityCancers 2019; 11(9): 1402 doi: 10.3390/cancers11091402
13
Masayoshi Takeuchi. Toxic AGEs (TAGE) theory: a new concept for preventing the development of diseases related to lifestyleDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00614-3
14
Masayoshi Takeuchi. Serum Levels of Toxic AGEs (TAGE) May Be a Promising Novel Biomarker for the Onset/Progression of Lifestyle-Related DiseasesDiagnostics 2016; 6(2): 23 doi: 10.3390/diagnostics6020023
15
Masayoshi Takeuchi, Jun-ichi Takino, Akiko Sakasai-Sakai, Takanobu Takata, Mikihiro Tsutsumi. Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALDNutrients 2017; 9(6): 634 doi: 10.3390/nu9060634
16
Takanobu Takata, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Impact of intracellular toxic advanced glycation end-products (TAGE) on murine myoblast cell deathDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00561-z
17
Susana A. Palma-Duran, Meropi D. Kontogianni, Antonis Vlassopoulos, Shudong Zhao, Aikaterini Margariti, Michael Georgoulis, George Papatheodoridis, Emilie Combet. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adultsMetabolism 2018; 83: 120 doi: 10.1016/j.metabol.2018.01.023
18
Takanobu Takata, Tadashi Ueda, Akiko Sakasai-Sakai, Masayoshi Takeuchi. Generation of glyceraldehyde-derived advanced glycation end-products in pancreatic cancer cells and the potential of tumor promotionWorld Journal of Gastroenterology 2017; 23(27): 4910-4919 doi: 10.3748/wjg.v23.i27.4910
19
Ana‐Lucia Mayén, Elom K. Aglago, Viktoria Knaze, Reynalda Cordova, Casper G. Schalkwijk, Karl‐Heinz Wagner, Krasimira Aleksandrova, Veronika Fedirko, Pekka Keski‐Rahkonen, Michael F. Leitzmann, Verena Katzke, Bernard Srour, Matthias B. Schulze, Giovanna Masala, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Bas Bueno‐de‐Mesquita, Magritt Brustad, Antonio Agudo, María Dolores Chirlaque López, Pilar Amiano, Bodil Ohlsson, Stina Ramne, Dagfinn Aune, Elisabete Weiderpass, Mazda Jenab, Heinz Freisling. Dietary intake of advanced glycation endproducts and risk of hepatobiliary cancers: A multinational cohort studyInternational Journal of Cancer 2021; 149(4): 854 doi: 10.1002/ijc.33612
20
David Schröter, Annika Höhn. Role of Advanced Glycation End Products in Carcinogenesis and their Therapeutic ImplicationsCurrent Pharmaceutical Design 2019; 24(44): 5245 doi: 10.2174/1381612825666190130145549
21
Zhong-qun Wang, Le-le Jing, Jin-chuan Yan, Zhen Sun, Zheng-yang Bao, Chen Shao, Qi-wen Pang, Yue Geng, Li-li Zhang, Li-hua Li. Role of AGEs in the progression and regression of atherosclerotic plaquesGlycoconjugate Journal 2018; 35(5): 443 doi: 10.1007/s10719-018-9831-x